Legacy Bridge’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Legacy Bridge's PFE Position: Q2 2026 in Review
Legacy Bridge increased its Pfizer (PFE) stake by 5.3% in Q2 2026, buying an estimated $41.9K and bringing the position to 31,979 shares worth $770K. The position accounts for 0.24% of the portfolio, ranked #107.
Legacy Bridge first reported a position in PFE in Q4 2018 and has held it in 27 quarters since. The position peaked at $853K in Q1 2026. 2,829 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Legacy Bridge held 31,979 shares of Pfizer worth $770K as of Q2 2026.
- Legacy Bridge bought 1,600 Pfizer shares in Q2 2026, an estimated $41.9K.
- Pfizer made up 0.24% of Legacy Bridge's portfolio in Q2 2026, its #107 holding.
- Legacy Bridge first reported a position in Pfizer in Q4 2018 and has held it in 27 quarters since.
- Legacy Bridge's Pfizer position peaked at $853K in Q1 2026.
- 2,829 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Legacy Bridge's 13F filing for Q2 2026, filed 13 Aug 2026.